SuperworthUnitedHealth Group Incorporated UNH
Medical - Healthcare Plans, Healthcare
$375.98
−0.09%
- Market cap
- $337.5B
- PE
- 24.2×
- 10y median 22.4×
- Forward PE
- Price to sales
- 0.7×
- EV/EBIT
- 15.9×
- Revenue, 12 months
- $450.1B
- +6% on a year ago
- Net margin
- 3.1%
- Free cash flow yield
- 7.0%
UnitedHealth trades at 24.2× trailing earnings, pricier than 69% of the last ten years. Revenue was $450.1B over the last twelve months, up 6% on a year earlier with a 3% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $94.4B | $99.8B | $98.9B | $100.8B | $100.8B+7% | $109.6B+10% | $111.6B+13% | $113.2B+12% | $113.2B+12% | $111.7B+2% | $112B+0% | |
| Cost of revenue | $72.4B | $76.8B | $76.8B | $77.8B | $79.5B+10% | $85.8B+12% | $91.6B+19% | $92.5B+19% | $94.7B+19% | $86.3B+1% | $75.4B−18% |
| Gross profit | $22B | $23B | $22.1B | $23B | $21.3B−3% | $23.8B+3% | $20B−9% | $20.6B−10% | $18.5B−13% | $25.4B+7% | $36.7B+83% |
| SG&A | $13.3B | $14.1B | $13.2B | $13.3B | $12.5B−6% | $13.6B−3% | $13.8B+5% | $15.2B+15% | $17B+36% | $15.4B+13% | $14.3B+4% |
| $7.7B | $7.9B | $7.9B | $8.7B | $7.8B+1% | $9.1B+15% | $5.2B−35% | $4.3B−50% | $380M−95% | $9B−1% | $8B+55% | |
| Interest expense | $830M | $844M | $985M | $1.1B | $1B+21% | $998M+18% | $1B+4% | $1B−7% | $974M−3% | $955M−4% | $962M−6% |
| Pre-tax income | $6.9B | $1M | $5.7B | $7.6B | $6.8B−1% | $8.1B+810500% | $4.1B−28% | $3.2B−58% | −$720M | $8B−2% | $7B+71% |
| $1.2B | $1.2B | $1.2B | $1.4B | $1B−15% | $1.6B+34% | $510M−59% | $686M−49% | −$938M | $1.5B−9% | $1.3B+155% | |
| Net income | $5.5B | −$1.4B | $4.2B | $6.1B | $5.5B+2% | $6.3B | $3.4B−19% | $2.3B−61% | $10M−100% | $6.3B−0% | $5.5B+61% |
| $5.83 | −$1.53 | $4.54 | $6.51 | $5.98+3% | $6.85 | $3.74−18% | $2.59−60% | $0.01−100% | $6.90+1% | $6.04+62% | |
| 935M | 922M | 928M | 930M | 927M−1% | 918M−0% | 910M−2% | 908M−2% | 910M−2% | 910M−1% | 906M−0% |
From each company's 10-Q and 10-K filings. Fiscal years are four fiscal quarters added up; balance sheet lines are as of the period's end. Growth is on the same period a year earlier.
Estimates
Next earnings report: .
Analyst consensus for the next eight quarters, with the range from the lowest to the highest estimate, is part of Superworth Pro.
Peers
Companies in Medical - Healthcare Plans within ten times UnitedHealth's size, closest in size first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| UNHUnitedHealth Group Incorporated | $337.5B | 24.2× | 22.4× | 0.7× | +6% | 3.1% | |
| CVSCVS Health Corp. | $112.5B | 23.3× | 16.2× | 0.3× | +7% | 1.2% | |
| ELVElevance Health Inc. | $87.7B | 18.0× | 17.6× | 0.4× | +6% | 2.5% | |
| CICigna Corporation | $73.6B | 11.5× | 16.1× | 0.3× | +8% | 2.3% | |
| HUMHumana Inc. | $47.6B | 37.5× | 20.5× | 0.3× | +18% | 0.9% | |
| Peer median | $80.6B | 20.6× | 16.9× | 0.3× | +8% | 1.7% |
About
- Chief executive
- Stephen Hemsley, since 2025Returned as CEO in May 2025 after leading from 2006 to 2017. Source
- Industry
- Medical - Healthcare Plans
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .